UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing

Genome Biology, 2022-07, Vol.23 (1), p.1-158, Article 158

2022

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Primary and acquired resistance in lung cancer

Frontiers in oncology, 2023-11, Vol.13, p.1310331-1310331

2023

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management

Journal of clinical medicine, 2024-03, Vol.13 (6), p.1574

2024

Link zum Volltext

Verfügbarkeit prüfen

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients

Molecular cancer, 2021-02, Vol.20 (1), p.32-32, Article 32

2021

Link zum Volltext

Verfügbarkeit prüfen

Implications of KRAS mutations in acquired resistance to treatment in NSCLC

Oncotarget, 2018-01, Vol.9 (5), p.6630-6643

2018

Link zum Volltext

Verfügbarkeit prüfen

A patient with a Germline (p.R776H) EGFR Mutation With Multiple Lung Cancers Harboring Different Somatic EGFR Mutations

Clinical lung cancer, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation

Nature communications, 2022-06, Vol.13 (1), p.3298-3298, Article 3298

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas

Cancers, 2023-12, Vol.16 (1), p.166

2023

Link zum Volltext

Verfügbarkeit prüfen

Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer

Frontiers in oncology, 2020-12, Vol.10, p.593831-593831

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results

Frontiers in immunology, 2021-02, Vol.11, p.573156-573156

2021

Link zum Volltext

Verfügbarkeit prüfen

ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach

Cancers, 2022-05, Vol.14 (11), p.2592

2022

Link zum Volltext

Verfügbarkeit prüfen

Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells

Frontiers in cell and developmental biology, 2014-05, Vol.2, p.20-20

2014

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal Stem Cell in Pancreatic Islet Transplantation

Biomedicines, 2023-05, Vol.11 (5), p.1426

2023

Link zum Volltext

Verfügbarkeit prüfen

Somatic mutations of thymic epithelial tumors with myasthenia gravis

Frontiers in oncology, 2023-08, Vol.13, p.1224491-1224491

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression

Translational oncology, 2024-03, Vol.41, p.101869-101869, Article 101869

2024

Link zum Volltext

Verfügbarkeit prüfen

Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation

Frontiers in oncology, 2021-06, Vol.11

2021

Link zum Volltext

Verfügbarkeit prüfen

Biology of MET: a double life between normal tissue repair and tumor progression

Annals of translational medicine, 2015-04, Vol.3 (6), p.82-82

Petrini, Iacopo

2015

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC

British journal of cancer, 2018-03, Vol.118 (6), p.820-824

2018

Link zum Volltext

Verfügbarkeit prüfen

Growth Factor Content in Human Sera Affects the Isolation of Mesangiogenic Progenitor Cells (MPCs) from Human Bone Marrow

Frontiers in cell and developmental biology, 2016-10, Vol.4, p.114-114

2016

Link zum Volltext

Verfügbarkeit prüfen

Thymectomy in Myasthenic Patients With Thymoma: Killing Two Birds With One Stone

The Annals of thoracic surgery, 2021-12, Vol.112 (6), p.1782-1789

2021

Link zum Volltext

Verfügbarkeit prüfen

Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations

OncoTargets and therapy, 2022-01, Vol.15, p.1197-1210

2022

Link zum Volltext

Verfügbarkeit prüfen

Dabrafenib-trametinib in BRAF V600-mutated non-small-cell lung cancer: a single center real world experience

Future oncology (London, England), 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer

Cell death and differentiation, 2018-07, Vol.25 (7), p.1239-1258

2018

Link zum Volltext

Verfügbarkeit prüfen

Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC

Lung cancer (Amsterdam, Netherlands), 2023-09, Vol.183, p.107308-107308, Article 107308

2023

Link zum Volltext

Verfügbarkeit prüfen

Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival

Clinical lung cancer, 2022-09, Vol.23 (6), p.510-521

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Zeitschrift / SerieEuropean Journal Of Clinical Investigation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(48)
Berichte
(2)

Sprache

Englisch
(50)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing

Editorial: Primary and acquired resistance in lung cancer

Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients

Implications of KRAS mutations in acquired resistance to treatment in NSCLC

A patient with a Germline (p.R776H) EGFR Mutation With Multiple Lung Cancers Harboring Different Somatic EGFR Mutations

Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation

Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas

Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer

Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results

ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach

Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells

Mesenchymal Stem Cell in Pancreatic Islet Transplantation

Somatic mutations of thymic epithelial tumors with myasthenia gravis

Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression

Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation

Biology of MET: a double life between normal tissue repair and tumor progression

PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC

Growth Factor Content in Human Sera Affects the Isolation of Mesangiogenic Progenitor Cells (MPCs) from Human Bone Marrow

Thymectomy in Myasthenic Patients With Thymoma: Killing Two Birds With One Stone

Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations

Dabrafenib-trametinib in BRAF V600-mutated non-small-cell lung cancer: a single center real world experience

The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer

Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC

Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival

Aktive Filter

Suchergebnisse filtern